Basilea Pharma names Ditzinger as CTO; Ghana offering pharma technology training; Halo names new CEO, CFO;

> Basilea Pharmaceutica ($BSLN) has named Dr. Günter Ditzinger to succeed Dr. Heinze-Krauss as chief technology officer effective Feb. 1, 2016. Ditzinger also was named a member of the management committee. More

> The National Vocational Training Institute of Ghana is teaming with a German development agency to offer a pharmaceutical manufacturing technology program for qualified applicants. Story

> New Jersey-based Halo Pharmaceutical, a CDMO, has named Lee Karras as its new CEO, and Barry Lederman as its CFO. Announcement

Suggested Articles

Gilead Sciences will add 140 jobs to its Irish operations as part of an expansion to its Dublin distribution center, the Irish Times reported.

GSK's Shingrix supply has recovered after COVID-19 prompted a slowdown in vaccinations.

Moderna will delegate fill-finish duties for "hundreds of millions" of doses of its COVID-19 vaccine to Spain's Laboratorios Farmacéuticos Rovi.